Work

Second-line combination chemotherapy: A phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic hormone-refractory prostate cancer (HRPC) refractory to docetaxel-based therapy

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.5151

Authors: A. L. Harzstark, V. K. Weinberg, J. Sharib, D. C. Smith, M. H. Hussain, T. M. Beer, C. W. Ryan, P. Mathew, C. J. Ryan, E. J. Small, J. E. Rosenberg

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591012916

Cites:

Cited by: 4

Related to: 10